Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 38, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 April 2026 - 13:25

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 38, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tecentriq

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters